Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update
Developed first to treat diabetes but quickly distinguished for their weight-loss outcomes, the interest in (and popularity of) GLP-1 drugs shows no sign of slowing down today as availability expands and more people whether its a celebrity on the big screen or your neighbor down the street noticeably shed pounds after using them, said Julie Stich, the vice president of content at the International Foundation of Employee Benefit Plans (IFEBP), an education, research and networking organization
These findings suggest potential therapeutic benefits beyond glycemic control and highlight the need for further investigation into SGLT2 inhibitors as part of post-COVID-19 management strategies
doi: 10.1016/S0167-0115(03)00111-3
Standard Protocol (Weeks 3-8) After the initial adaptation period, most individuals progress to the standard 5-amino-1MQ dosage of 75mg daily
It is especially important because it is one of the more clinically developed members of the GHRH analog family
